323 related articles for article (PubMed ID: 82152)
1. New leads for trypanosomiasis chemotherapy.
Lancet; 1978 Dec; 2(8101):1190. PubMed ID: 82152
[No Abstract] [Full Text] [Related]
2. Trypanocidal drugs: mechanisms, resistance and new targets.
Wilkinson SR; Kelly JM
Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
[TBL] [Abstract][Full Text] [Related]
3. Trypanosomes at the gates.
Cross GA
Science; 2005 Jul; 309(5733):355. PubMed ID: 16020696
[No Abstract] [Full Text] [Related]
4. Trypanocidal Essential Oils: A Review.
Morais MC; Souza JV; da Silva Maia Bezerra Filho C; Dolabella SS; Sousa DP
Molecules; 2020 Oct; 25(19):. PubMed ID: 33036315
[TBL] [Abstract][Full Text] [Related]
5. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
6. Parasitology. Drugs to combat tropical protozoan parasites.
Gelb MH; Hol WG
Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
[No Abstract] [Full Text] [Related]
7. [Rational concepts and the study of active molecules against various trypanosomiases].
Périé J; de Albuquerque C; Blonski C; Chauvière G; Gefflaut T; Page P; Trinquier M; Willson M
Bull Soc Pathol Exot; 1994; 87(5):353-61. PubMed ID: 7496200
[TBL] [Abstract][Full Text] [Related]
8. Anti-sleeping sickness drugs and cancer chemotherapy.
Barrett SV; Barrett MP
Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
[No Abstract] [Full Text] [Related]
9. Applicability of plant-based products in the treatment of Trypanosoma cruzi and Trypanosoma brucei infections: a systematic review of preclinical in vivo evidence.
Pereira RM; Greco GMZ; Moreira AM; Chagas PF; Caldas IS; Gonçalves RV; Novaes RD
Parasitology; 2017 Sep; 144(10):1275-1287. PubMed ID: 28578742
[TBL] [Abstract][Full Text] [Related]
10. Existing chemotherapy and its limitations.
Gutteridge WE
Br Med Bull; 1985 Apr; 41(2):162-8. PubMed ID: 3161577
[No Abstract] [Full Text] [Related]
11. Chemotherapy of African trypanosomiasis.
Williamson J
Trop Dis Bull; 1976 Jul; 73(7):531-42. PubMed ID: 135387
[No Abstract] [Full Text] [Related]
12. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
Croft SL; Snowdon D; Yardley V
J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
[TBL] [Abstract][Full Text] [Related]
13. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
Simarro PP; Asumu PN
Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
[No Abstract] [Full Text] [Related]
14. [Melarsoprol].
Simon F
Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741
[No Abstract] [Full Text] [Related]
15. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story.
Baker N; de Koning HP; Mäser P; Horn D
Trends Parasitol; 2013 Mar; 29(3):110-8. PubMed ID: 23375541
[TBL] [Abstract][Full Text] [Related]
16. Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine.
Steverding D; Rushworth SA
Exp Parasitol; 2017 Jul; 178():45-50. PubMed ID: 28552794
[TBL] [Abstract][Full Text] [Related]
17. Randomized, controlled trial of treatments for second-stage sleeping sickness.
Woodrow CJ; Abel PM; Krishna S
J Infect Dis; 2007 Aug; 196(4):650-1. PubMed ID: 17624857
[No Abstract] [Full Text] [Related]
18. Trypanocidal activity of marine natural products.
Jones AJ; Grkovic T; Sykes ML; Avery VM
Mar Drugs; 2013 Oct; 11(10):4058-82. PubMed ID: 24152565
[TBL] [Abstract][Full Text] [Related]
19. Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen.
Jennings FW; Rodgers J; Bradley B; Gettinby G; Kennedy PG; Murray M
Parasitol Int; 2002 Dec; 51(4):381-8. PubMed ID: 12421636
[TBL] [Abstract][Full Text] [Related]
20. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
